← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Hackensack University Medical Center
Hackensack, NJ
$242,943,955
Total funding
119
Grants
Funding over time
peak $157.4M · FY2005–25$200M$150M$100M$50M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$242,848,955 · 118
CDC$95,000 · 1
By mechanism
U19$108,173,860 · 42
R01$102,839,633 · 45
R21$6,641,682 · 15
UG3$5,742,893 · 1
UH3$5,019,949 · 1
U01$4,191,473 · 2
Investigators at Hackensack University Medical Center
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Metropolitan AntiViral Drug Accelerator$65,141,731
U19 · FY2022 · AI
High Throughput Screening Core$8,363,749
U19 · FY2022 · AI
Discovery and Optimization of Inhibitors of SARS-CoV-2 Polymerase and Exonuclease$8,152,463
U19 · FY2022 · AI
Center for accelerated development of drug candidates targeting high threat bacterial infections$7,562,521
U19 · FY2025 · AI
Administrative Core$7,558,755
U19 · FY2022 · AI
Center to develop innovative therapeutics to multidrug resistant high-threat bacterial agents$6,880,060
U19 · FY2019 · AI
Center to develop innovative therapeutics to multidrug resistant high-threat bacterial agents$6,639,071
U19 · FY2021 · AI
Center to develop innovative therapeutics to multidrug resistant high-threat bacterial agents$6,638,250
U19 · FY2022 · AI
Center to develop innovative therapeutics to multidrug resistant high-threat bacterial agents$6,638,108
U19 · FY2020 · AI
Center to develop innovative therapeutics to multidrug resistant high-threat bacterial agents$6,521,325
U19 · FY2023 · AI
Discovery of new antiviral methylase, protease, and helicase inhibitors of corona-, flavi-, and alphaviruses$5,701,101
U19 · FY2022 · AI
Animal Model Core$5,580,377
U19 · FY2022 · AI
Structural Biology and Computational Modeling Core$5,326,632
U19 · FY2022 · AI
Virology Core$5,289,678
U19 · FY2022 · AI
Enriching ECHO Cohorts with High-risk Pregnancies and Children with Health Challenges (Enriching ECHO)$5,019,949
UH3 · FY2025 · OD
Development of ALG-097431 as a broad-spectrum 3CL pro inhibitor$4,228,031
U19 · FY2022 · AI
Medicinal Chemistry Core$4,033,569
U19 · FY2022 · AI
Accelerated development of advanced leads against SARS-CoV-2 and other pandemic viruses$3,885,770
U19 · FY2022 · AI
Enriching ECHO Cohorts with High-risk Pregnancies and Children with Disabilities (Enriching ECHO)$3,669,385
UG3 · FY2024 · OD
Multiplex Small Molecule Discovery to Identify Broad-Acting Viral Protease Inhibitors$3,545,618
U19 · FY2022 · AI